Published in Cancer Immunol Immunother on December 01, 2004
Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells. Clin Exp Immunol (2010) 0.92
Mycobacterium bovis bacillus Calmette-Guérin-induced macrophage cytotoxicity against bladder cancer cells. Clin Dev Immunol (2010) 0.87
Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2009) 0.79
Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation. BMC Immunol (2009) 0.75
Nomenclature of monocytes and dendritic cells in blood. Blood (2010) 6.63
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother (2005) 3.20
Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients. Clin Immunol (2011) 2.78
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat (2007) 2.21
Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother (2009) 1.55
The number of circulating CD4+ CD25high Foxp3+ T lymphocytes is transiently elevated in the early childhood of transient hypogammaglobulinemia of infancy patients. Clin Immunol (2011) 1.47
Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res (2003) 1.45
Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett (2007) 1.43
Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal (2013) 1.15
Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol (2004) 1.05
Tumor cell-induced deactivation of human monocytes. J Leukoc Biol (2003) 0.96
Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells. J Pharmacol Exp Ther (2002) 0.96
Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J Immunol (2004) 0.94
Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors. J Leukoc Biol (2007) 0.93
Human monocytes both enhance and inhibit the growth of human pancreatic cancer in SCID mice. Anticancer Res (2008) 0.92
Sepsis caused by Veillonella parvula infection in a 17-year-old patient with X-linked agammaglobulinemia (Bruton's disease). J Clin Microbiol (2006) 0.92
Circulating tumour cells and survival of patients with gastric cancer. Anticancer Res (2007) 0.90
Caspase-8 activation precedes alterations of mitochondrial membrane potential during monocyte apoptosis induced by phagocytosis and killing of Staphylococcus aureus. Infect Immun (2004) 0.87
Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience. J Clin Immunol (2011) 0.86
Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer (2004) 0.85
Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome. Arch Immunol Ther Exp (Warsz) (2008) 0.85
Blood monocytes stimulate migration of human pancreatic carcinoma cells in vitro: the role of tumour necrosis factor - alpha. Eur J Cell Biol (2009) 0.83
Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells. J Pharmacol Exp Ther (2002) 0.83
Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells. Anticancer Res (2012) 0.82
Circulating CXCR4-positive stem/progenitor cells compete for SDF-1-positive niches in bone marrow, muscle and neural tissues: an alternative hypothesis to stem cell plasticity. Folia Histochem Cytobiol (2003) 0.82
Tumour-derived microvesicles contain interleukin-8 and modulate production of chemokines by human monocytes. Anticancer Res (2011) 0.81
Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer Res (2009) 0.81
Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells. Anticancer Res (2004) 0.80
Intrauterine exposure to lead may enhance sensitization to common inhalant allergens in early childhood: a prospective prebirth cohort study. Environ Res (2010) 0.80
Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer. Pol J Pathol (2007) 0.79
Risk of wheezing associated with house-dust mite allergens and indoor air quality among three-year-old children. Kraków inner city study. Int J Occup Med Environ Health (2007) 0.79
The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism. Int J Mol Med (2010) 0.79
Tumour-derived microvesicles (TMV) mimic the effect of tumour cells on monocyte subpopulations. Anticancer Res (2010) 0.78
Interactions of monocyte subpopulations generated from cord blood CD34(+) hematopoietic progenitors with tumor cells: assessment of antitumor potential. Exp Hematol (2012) 0.78
Properties of monocytes generated from haematopoietic CD34(+) stem cells from bone marrow of colon cancer patients. Cancer Immunol Immunother (2012) 0.78
Immunophenotypic changes and induction of apoptosis of monocytes and tumour cells during their interactions in vitro. Anticancer Res (2003) 0.77
The B-cell compartment in the peripheral blood of children with different types of primary humoral immunodeficiency. Pediatr Res (2009) 0.77
The expression of CD40 on monocytes of children with primary humoral immunodeficiencies. Pediatr Res (2006) 0.76
Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody. Cancer Immun (2004) 0.76
Detection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression. Oncol Rep (2008) 0.76
Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome. Pediatr Transplant (2008) 0.76
Biological activity of dendritic cells generated from cord blood CD34+ hematopoietic progenitors in IL-7- and IL-13-conditioned cultures. Arch Immunol Ther Exp (Warsz) (2009) 0.75
Depressed tumor necrosis factor alpha and interleukin-12p40 production by peripheral blood mononuclear cells of gastric cancer patients: association with IL-1R-associated kinase-1 protein expression and disease stage. Int J Cancer (2005) 0.75
Interactions of human monocytes with TMVs (tumour-derived microvesicles). Biochem Soc Trans (2013) 0.75
Recognition of apoptotic cells by human peripheral blood monocytes does not alter their ability to phagocytize and kill Staphylococcus aureus. Arch Immunol Ther Exp (Warsz) (2004) 0.75
Extracellular matrix proteins modulate cytokine production by monocytes during their interactions with cancer cells. Anticancer Res (2003) 0.75